- Egide Kayitare (2010). Development of solid paediatric oral dosage forms. Promotors: Jean Paul Remon / Chris Vervaet
- Katrien Van Damme (2010). Development of Gantrez AN nanoparticles for oral delivery of antigens. Promotors: Jean Paul Remon / Chris Vervaet
- Eva Neirinckx (2010). Towards a veterinary biopharmaceutical classification system: oral bioavailability and ex vivo intestinal permeability studies of paracetamol and ketoprofen in different animal species. Promotors: Siska Croubels / Chris Vervaet – Co-Promotor: Patrick De Backer
- Matthieu Ravelingien (2010). Development of Titanium bone scaffolds with drug delivery systems. Promotors: Jean Paul Remon / Chris Vervaet - Co-Promotors: Jan Luyten / Steven Mullens
- Thomas Quinten (2011). Evaluation of injection moulding as a pharmaceutical production technology for sustained-release matrix tablets. Promotors: Jean Paul Remon / Chris Vervaet
- Ana Almeida (2012).Hot melt extrusion of ethylene vinyl acetate for oral sustained-release applications. Promotors: Jean Paul Remon / Chris Vervaet
- Katrien Huyge (2012). Dry powder vaccines as tool for mass vaccination against Newcastle disease in poultry. Promotors: Chris Vervaet / Wil Landman - Co-Promotor: Jean Paul Remon
- Anneleen Burggraeve (2012). Development of process analytical and control methodologies for pharmaceutical wet granulation processes. Promotors: Thomas De Beer - Co-Promotor: Chris Vervaet
- Samatha Mehta (2013). Multiparticulates for vaginal drug delivery. Promotors: Jean Paul Remon / Chris Vervaet / Hans Verstraelen
- Lien Saerens (2013). Spectroscopic process monitoring for quality assessment, visualization and understanding of pharmaceutical hot-melt extrusion. Promotor: Thomas De Beer - Co-Promotor: Chris Vervaet
- Lieselotte De Smet (2013). Treatment of peritoneal carcinomatosis via (hyperthermic) intraperitoneal chemotherapy: towards a unified standard of care. Promotors: Chris Vervaet / Jean Paul Remon / Wim Ceelen
- Lien Dierickx (2014). Hot-melt extrusion as manufacturing technique for multilayer oral solid dosage forms. Promotors: Chris Vervaet / Jean Paul Remon
- Elisabeth Peeters (2014). Investigation of the tableting process in continuous production: influence of feeding and extended dwell time during compression on the dependent process variables and tablet properties. Promotors: Chris Vervaet / Jean Paul Remon
- Jurgen Vercruysse (2014). Innovation in pharmaceutical manufacturing of solid dosage forms via continuous wet granulation Promotors: Chris Vervaet / Jean Paul Remon / Ivo Van Assche
- An-Katrien Vynckier (2015). Co-extrusion as a continuous production process for fixed-dose combination dosage forms. Promotors: Jean Paul Remon / Chris Vervaet
- Bart Claeys (2015). Non-conventional polymers as matrix excipients for hot melt extruded oral-release formulations. Promotors: Jean Paul Remon / Chris Vervaet
- Anouk Vervaeck (2015). Prilling of fatty acids as innovative technology for oral controlled release multiple-unit systems. Promotors: Jean Paul Remon / Chris Vervaet
- Wesley De Jaeghere (2016). Partially hydroluzed polyvinylalcohol as functional excipient in oral solid dosage forms prepared via extrusion. Promotors: Jean Paul Remon / Chris Vervaet
- Tinne Monteyne (2016). Development of formulation and process knowledge for continuous twin-screw melt granulation. Promotor: Thomas De Beer, co-Promotor: Chris Vervaet
- Valérie Vanhoorne (2016). Towards continuous pharmaceutical tablet manufacturing: implementation of continuous agglomeration techniques. Promotors: Jean Paul Remon / Chris Vervaet
- Glenn Verstraete (2017). Thermoplastic polyurethanes for the manufacturing of high drug loaded sustained release matrices. Promotors: Jean Paul Remon / Chris Vervaet
- Nina Willecke (2018). Formulation design for continuous twin screw wet granulation. Promotors: Chris Vervaet, Thomas De Beer, Aniko Szepes, Martin Wunderlich
- Wouter Grymonpré (2018). Increasing pharmaceutical process understanding for twin-screw extrusion and tablet manufacturing. Promotors: Chris Vervaet / Jean Paul Remon
- Bernd Van Snick (2019). Experimental and model-based analysis of a continuous direct compression platform for oral solid dosage manufacturing. Promotor: Chris Vervaet
- Kaat De Clercq (2019). Development of paclitaxel-loaded gelatin microspheres with a dual application for the treatment of advanced ovarian cancer: prevention of postsurgical peritoneal adhesions and recurrence of peritoneal carcinomatosis. Promotors: Chris Vervaet / Wim Ceelen
- Elien De Coninck (2020). Prilling of API/fatty acid suspensions: an innovative pharmaceutical production technique for multiparticulate dosage forms. Promotors: Chris Vervaet / Valérie Vanhoorne
- Christoph Portier (2021). Improved Process and Formulation Understanding During Continuous Twin Screw Wet Granulation and Downstream Processing. Promotors: Chris Vervaet / Valérie Vanhoorne
- Lise Vandevivere (2021). The impact of binders on formulation design in a continuous pharmaceutical manufacturing process based on twin screw wet granulation. Promotors: Chris Vervaet / Valérie Vanhoorne
- Bram Bekaert (2021). Continuous direct compression: improved process knowledge about the feeding and blending unit operation. Promotors: Chris Vervaet / Valérie Vanhoorne
- Aseel Samaro (2021). Innovative applications of hot-melt extrusion and additive manufacturing for the development of oral solid dosage forms. Promotors: Chris Vervaet / Valérie Vanhoorne
- Joris Lammens (2022). Development and characterisation of a continuous freeze-drying technology for unit doses. Promotors: Chris Vervaet / Thomas De Beer
- Cedrine de Backere (2022).Impact of lubrication on process and tablet quality in direct compression. Promotors: Chris Vervaet / Valérie Vanhoorne
- Jana Becelaere (2023). Making the insoluble soluble: PEtOx based amorphous solid dispersions with high drug loadings using solvent electrospinning as a formulation technique. Promotors: Karen De Clerck, Richard Hoogenboom, Chris Vervaet
- Silke Henry (2023). Evaluation of fused filament fabrication for oral solid dosage form production. Promotors: Chris Vervaet, Valérie Vanhoorne
- Elisa De Pauw (2023). Co-spray drying for continuous tablet manufacturing of conventional formulations. Promotors: Valérie Vanhoorne, Chris Vervaet
- Milan Decorte (2024). Radical improvements in the use of existing and novel antioxidants in pharmaceutical oral solid dosage form. Promotors: Valérie Vanhoorne, Ben Vanhove, Chris Vervaet
- Tom Verbeke (2025). Boosting powder flow: how flow enhancers revolutionize continuous direct compression. Promotors: Valérie Vanhoorne, Chris Vervaet
- Phaedra Denduyver (2025). Revolutionizing controlled release formulations: unlocking the potential of twin-screw wet granulation and semi-continuous pan coating. Promotors: Valérie Vanhoorne, Chris Vervaet
- Alexander De Man (2025). Advancements in continuous direct compression: surrogate material studies and novel PAT applications. Promotors: Thomas De Beer, Valérie Vanhoorne